N-nitroso-2-acetylaminofluorene: A direct-acting carcinogen inducing hepatocellular carcinoma in Sprague-Dawley rats

Y. S. Ho, J. K. Lin

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

To compare the hepatotoxicity and hepatocarcinogenicity of N-nitroso-2-acetylaminofluorene (NO-AAF) and its parent compound, 2-acetylaminofluorene (AAF), male Sprague-Dawley rats were given intraperitoneal (i.p.) or subcutaneous (s.c.) injections of AAF or NO-AAF (60 mg/kg body weight/week) for ten months. In the AAF group, morphological changes were produced which involved gross distortions of the liver with multiple nodule formations. The rat livers in the NO-AAF group appeared to be smooth with a blunt-thick superior segment of the lateral lobe. The serum γ-glutamyl transpeptidase activity in both the AAF group and the NO-AAF group was significantly elevated (P <0.0005). The present study shows that i.p. and s.c. injections of NO-AAF resulted in a high incidence of well-differentiated hepatocellular carcinomas (HCC) (7/9 and 4/6, respectively), while poorly differentiated HCCs were induced by i.p. or s.c. administration of AAF (6/9 or 2/6, respectively). Subcutaneous lesions consisting of an inflammatory reaction and fibroadenoma formation were observed in the NO-AAF-treated rats, whereas no such skin lesions were detected in the AAF-treated animals. These results suggest that NO-AAF is a new direct-acting carcinogen which may be useful for investigating hepatocarcinogenesis.

Original languageEnglish
Pages (from-to)794-800
Number of pages7
JournalJapanese Journal of Cancer Research
Volume85
Issue number8
Publication statusPublished - 1994
Externally publishedYes

Fingerprint

2-Acetylaminofluorene
Carcinogens
Sprague Dawley Rats
Hepatocellular Carcinoma
Subcutaneous Injections
Intraperitoneal Injections
N-nitroso-N(2)-fluorenylacetamide
Fibroadenoma
gamma-Glutamyltransferase
Liver

Keywords

  • γ-glutamyl transpeptidase
  • AAF
  • Fibroadenoma
  • Hepatocarcinogenicity
  • NO-AAF

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

@article{b0fd3d60e0ef421b966e425d09ffa2ab,
title = "N-nitroso-2-acetylaminofluorene: A direct-acting carcinogen inducing hepatocellular carcinoma in Sprague-Dawley rats",
abstract = "To compare the hepatotoxicity and hepatocarcinogenicity of N-nitroso-2-acetylaminofluorene (NO-AAF) and its parent compound, 2-acetylaminofluorene (AAF), male Sprague-Dawley rats were given intraperitoneal (i.p.) or subcutaneous (s.c.) injections of AAF or NO-AAF (60 mg/kg body weight/week) for ten months. In the AAF group, morphological changes were produced which involved gross distortions of the liver with multiple nodule formations. The rat livers in the NO-AAF group appeared to be smooth with a blunt-thick superior segment of the lateral lobe. The serum γ-glutamyl transpeptidase activity in both the AAF group and the NO-AAF group was significantly elevated (P <0.0005). The present study shows that i.p. and s.c. injections of NO-AAF resulted in a high incidence of well-differentiated hepatocellular carcinomas (HCC) (7/9 and 4/6, respectively), while poorly differentiated HCCs were induced by i.p. or s.c. administration of AAF (6/9 or 2/6, respectively). Subcutaneous lesions consisting of an inflammatory reaction and fibroadenoma formation were observed in the NO-AAF-treated rats, whereas no such skin lesions were detected in the AAF-treated animals. These results suggest that NO-AAF is a new direct-acting carcinogen which may be useful for investigating hepatocarcinogenesis.",
keywords = "γ-glutamyl transpeptidase, AAF, Fibroadenoma, Hepatocarcinogenicity, NO-AAF",
author = "Ho, {Y. S.} and Lin, {J. K.}",
year = "1994",
language = "English",
volume = "85",
pages = "794--800",
journal = "Cancer Science",
issn = "1347-9032",
publisher = "Wiley-Blackwell",
number = "8",

}

TY - JOUR

T1 - N-nitroso-2-acetylaminofluorene

T2 - A direct-acting carcinogen inducing hepatocellular carcinoma in Sprague-Dawley rats

AU - Ho, Y. S.

AU - Lin, J. K.

PY - 1994

Y1 - 1994

N2 - To compare the hepatotoxicity and hepatocarcinogenicity of N-nitroso-2-acetylaminofluorene (NO-AAF) and its parent compound, 2-acetylaminofluorene (AAF), male Sprague-Dawley rats were given intraperitoneal (i.p.) or subcutaneous (s.c.) injections of AAF or NO-AAF (60 mg/kg body weight/week) for ten months. In the AAF group, morphological changes were produced which involved gross distortions of the liver with multiple nodule formations. The rat livers in the NO-AAF group appeared to be smooth with a blunt-thick superior segment of the lateral lobe. The serum γ-glutamyl transpeptidase activity in both the AAF group and the NO-AAF group was significantly elevated (P <0.0005). The present study shows that i.p. and s.c. injections of NO-AAF resulted in a high incidence of well-differentiated hepatocellular carcinomas (HCC) (7/9 and 4/6, respectively), while poorly differentiated HCCs were induced by i.p. or s.c. administration of AAF (6/9 or 2/6, respectively). Subcutaneous lesions consisting of an inflammatory reaction and fibroadenoma formation were observed in the NO-AAF-treated rats, whereas no such skin lesions were detected in the AAF-treated animals. These results suggest that NO-AAF is a new direct-acting carcinogen which may be useful for investigating hepatocarcinogenesis.

AB - To compare the hepatotoxicity and hepatocarcinogenicity of N-nitroso-2-acetylaminofluorene (NO-AAF) and its parent compound, 2-acetylaminofluorene (AAF), male Sprague-Dawley rats were given intraperitoneal (i.p.) or subcutaneous (s.c.) injections of AAF or NO-AAF (60 mg/kg body weight/week) for ten months. In the AAF group, morphological changes were produced which involved gross distortions of the liver with multiple nodule formations. The rat livers in the NO-AAF group appeared to be smooth with a blunt-thick superior segment of the lateral lobe. The serum γ-glutamyl transpeptidase activity in both the AAF group and the NO-AAF group was significantly elevated (P <0.0005). The present study shows that i.p. and s.c. injections of NO-AAF resulted in a high incidence of well-differentiated hepatocellular carcinomas (HCC) (7/9 and 4/6, respectively), while poorly differentiated HCCs were induced by i.p. or s.c. administration of AAF (6/9 or 2/6, respectively). Subcutaneous lesions consisting of an inflammatory reaction and fibroadenoma formation were observed in the NO-AAF-treated rats, whereas no such skin lesions were detected in the AAF-treated animals. These results suggest that NO-AAF is a new direct-acting carcinogen which may be useful for investigating hepatocarcinogenesis.

KW - γ-glutamyl transpeptidase

KW - AAF

KW - Fibroadenoma

KW - Hepatocarcinogenicity

KW - NO-AAF

UR - http://www.scopus.com/inward/record.url?scp=0028021485&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028021485&partnerID=8YFLogxK

M3 - Article

C2 - 7928624

AN - SCOPUS:0028021485

VL - 85

SP - 794

EP - 800

JO - Cancer Science

JF - Cancer Science

SN - 1347-9032

IS - 8

ER -